Vifor Pharma AG (VIFN:SW) (GNHAY) PT Raised to CHF127 at UBS
Tweet
Share
E-mailGet Alerts VIFN:SW Hot Sheet
Price: $0.00 --0%
Rating Summary:
0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 22 | Down: 13 | New: 31
Rating Summary:
0 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 22 | Down: 13 | New: 31
Trade Now!
Join SI Premium – FREE
UBS analyst Laura Sutcliffe raised the price target on Vifor Pharma AG (VIFN:SW) (OTC: GNHAY) to CHF127.00 (from CHF119.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Neurocrine Bio. (NBIX) PT Raised to $138 at Stifel; Nice Ingrezza Beat and Better TRx Commentary
- TeamViewer (TMV:GR) (TMVWY) PT Lowered to EUR30 at Goldman Sachs
- Nexans SA (NEX:FP) (NXPRF) PT Raised to EUR86 at JPMorgan
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT Change, Intl RatingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
